The safety profile of EndeavorRx was consistent with that seen in all previous clinical studies of the product; the treatment was well-tolerated with no serious adverse events. EndeavorRx has been ...

After years of waiting, Akili Interactive has finally received FDA De Novo marketing authorization for EndeavorRx, its video-game digital therapeutic for children aged 8 to 12 years with ADHD. This is ...

Last summer, the U.S. Food and Drug Administration approved the first prescription video game, an iPhone and iPad app designed to improve cognitive function among children with attention ...

Akili Interactive has published the full data from its STARS-ADHD Adjunctive trial. The data builds upon the company's pivotal study of AKL-T01 (now available as EndeavorRx) and suggests the videogame ...

BOSTON--(BUSINESS WIRE)-- Akili Interactive (“Akili”), a leading digital medicine company, today announced the EndeavorRx® Expedition product registry, which aims to obtain feedback from patients ...

Computer games get a bad rap for their addictive elements and violent content but those conveniently ignore the wide variety of genres, content, and purposes available in such a broad medium. Even ...

Video games are often criticized for their addictive qualities and links to increased aggressiveness, but they also have been found to be useful in health care settings for physiotherapy and pain ...

Attention improvements were nearly three times as large as those in the pivotal trial that served as the basis for EndeavorRx’s FDA authorization for children with ADHD ages 8-12 Study data will be ...

BOSTON--(BUSINESS WIRE)--Akili Interactive (“Akili”), a leading prescription digital therapeutics company, today announced that EndeavorRx®, the first and only prescription video game treatment for ...